Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17698
Country/Region: Uganda
Year: 2016
Main Partner: Uganda Prisons Services
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $150,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $150,000
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 7
GEND_GBV Age/Sex: <10 Male 2017 4
GEND_GBV Age/Sex: 10-14 Female 2017 19
GEND_GBV Age/Sex: 10-14 Male 2017 4
GEND_GBV Age/Sex: 15-19 Female 2017 33
GEND_GBV Age/Sex: 15-19 Male 2017 6
GEND_GBV Age/Sex: 20-24 Female 2017 35
GEND_GBV Age/Sex: 20-24 Male 2017 7
GEND_GBV Age/Sex: 25-49 Female 2017 13
GEND_GBV Age/Sex: 25-49 Male 2017 7
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 12
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 29
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 106
GEND_GBV Number of people receiving post-GBV care 2017 135
GEND_GBV Sum of Age/Sex Disaggregates 2017 34
HTS_TST Age/sex: <1 2017 718
HTS_TST Age/sex: 1-9 2017 2,366
HTS_TST Age/sex: 10-14 Female 2017 2,042
HTS_TST Age/sex: 10-14 Male 2017 2,039
HTS_TST Age/sex: 15-19 Female 2017 4,134
HTS_TST Age/sex: 15-19 Male 2017 4,683
HTS_TST Age/sex: 20-24 Female 2017 6,204
HTS_TST Age/sex: 20-24 Male 2017 7,022
HTS_TST Age/sex: 25-49 Female 2017 9,510
HTS_TST Age/sex: 25-49 Male 2017 10,767
HTS_TST Age/sex: 50+ Female 2017 827
HTS_TST Age/sex: 50+ Male 2017 937
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,586
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,579
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 20,675
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,409
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 51,249
HTS_TST Service Delivery Point (Facility): Index testing 2017 5,879
HTS_TST Service Delivery Point (Facility): Inpatient 2017 12,952
HTS_TST Service Delivery Point (Facility): Other PITC 2017 3,464
HTS_TST Service Delivery Point (Facility): Outpatient 2017 17,954
HTS_TST Service Delivery Point (Facility): Pediatric 2017 6,966
HTS_TST Service Delivery Point (Facility): PMTCT 2017 2,367
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 530
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,137
HTS_TST Sum of Age/Sex disaggregates 2017 48,165
HTS_TST Sum of Aggregated Age/Sex <15 2017 7,165
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 44,084
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 51,249
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 91
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 91
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 189
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 145
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 285
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 215
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 434
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 332
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 35
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 31
HTS_TST_POS Test Result by Age: Positive: <1 2017 35
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 102
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 161
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 158
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 943
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 723
PMTCT_ART Already on ART at beginning of current pregnancy 2017 139
PMTCT_ART New on ART 2017 102
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,393
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 159
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 47
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 2
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 8
PMTCT_EID Sum of Infant Age disaggregates 2017 206
PMTCT_STAT By: Known positives at entry 2017 170
PMTCT_STAT By: Number of new positives identified 2017 86
PMTCT_STAT Number of new ANC and L&D clients 2017 2,453
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,393
PMTCT_STAT Sum of Positives Status disaggregates 2017 256
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 60
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 115
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 180
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 180
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 335
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 34
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 101
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 200
TB_SCREENDX Screen Results: Screened Positive for TB 2017 85
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 133
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 120
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,599
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,339
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 4,191
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 9
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 106
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 195
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 322
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 322
TX_CURR Age/Sex: <1 2017 7
TX_CURR Age/Sex: 1-9 2017 62
TX_CURR Age/Sex: 10-14 Female 2017 98
TX_CURR Age/Sex: 10-14 Male 2017 86
TX_CURR Age/Sex: 15-19 Female 2017 130
TX_CURR Age/Sex: 15-19 Male 2017 40
TX_CURR Age/Sex: 20-24 Female 2017 598
TX_CURR Age/Sex: 20-24 Male 2017 268
TX_CURR Age/Sex: 25-49 Female 2017 1,741
TX_CURR Age/Sex: 25-49 Male 2017 963
TX_CURR Age/Sex: 50+ Female 2017 130
TX_CURR Age/Sex: 50+ Male 2017 68
TX_CURR Aggregated Age/Sex: <15 Female 2017 133
TX_CURR Aggregated Age/Sex: <15 Male 2017 120
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,599
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,339
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 4,191
TX_CURR Sum of Age/Sex disaggregations 2017 170
TX_CURR Sum of Aggregated Age/Sex <15 2017 253
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,938
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 4,191
TX_NEW Aggregated Grouping by Age: <1 2017 2
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 59
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 51
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,003
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 518
TX_NEW By Age/Sex: 1-9 2017 24
TX_NEW By Age/Sex: 10-14 Female 2017 46
TX_NEW By Age/Sex: 10-14 Male 2017 38
TX_NEW By Age/Sex: 15-19 Female 2017 49
TX_NEW By Age/Sex: 15-19 Male 2017 15
TX_NEW By Age/Sex: 20-24 Female 2017 231
TX_NEW By Age/Sex: 20-24 Male 2017 105
TX_NEW By Age/Sex: 25-49 Female 2017 673
TX_NEW By Age/Sex: 25-49 Male 2017 373
TX_NEW By Age/Sex: 50+ Female 2017 50
TX_NEW By Age/Sex: 50+ Male 2017 25
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,631
TX_NEW Sum of Age/Sex disaggregates 2017 1,605
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,631
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,353
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,019
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 98
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 88
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,870
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 963
TX_PVLS Numerator: Indication: Routine 2017 3,019
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 106
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 96
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,078
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,073
TX_PVLS_den Denominator: Indication: Routine 2017 3,353
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 26
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 94
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 272
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 625
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 20
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 212
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 408
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 867
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,334
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,500
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 23
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 107
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 195
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 309
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 702
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 50
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 29
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 462
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 975
VMMC_CIRC By Age: 10-14 2017 443
VMMC_CIRC By Age: 15-19 2017 330
VMMC_CIRC By Age: 20-24 2017 159
VMMC_CIRC By Age: 25-29 2017 91
VMMC_CIRC By Age: 30-49 2017 91
VMMC_CIRC By Age: 50+ 2017 23
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 1,137
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 1,137
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 1,137
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 955